Novel quinazoline derivatives, a pharmaceutical composition containing such derivatives as active ingredient and a process for producing the quinazoline derivatives
申请人:Mitsubishi Yuka Pharmaceutical Co., Ltd.
公开号:EP0028031A1
公开(公告)日:1981-05-06
There are presented novel quinazoline derivatives, namely 2-(4-substituted-carbamoyl-piperazin-1-yl)quinazoline derivatives, 2-(4-substituted-carbamoyl-homopiperazin-1--yl)quinazoline derivatives, 2-(4-substituted-thiocarbamoyl--piperazin-a-yl)quinazoline derivatives and 2-(4-substituted--thiocarbamoyl-piperazin-1-yl)quinazoline derivatives and a process for producing same. In form of pharmaceutical preparation said derivatives exhibit excellent antihypertensive activities.
本文介绍了新型
喹唑啉衍
生物,即 2-(4-取代-
氨基甲酰基-
哌嗪-1-基)
喹唑啉衍
生物、2-(4-取代-
氨基甲酰基-
高哌嗪-1-基)
喹唑啉衍
生物、2-(4-取代-
硫代
氨基甲酰基-
哌嗪-a-基)
喹唑啉衍
生物和 2-(4-取代-
硫代
氨基甲酰基-
哌嗪-1-基)
喹唑啉衍
生物及其生产工艺。上述衍
生物以药物制剂的形式表现出卓越的抗高血压活性。